{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T01:37:40Z","timestamp":1768268260738,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bcmd.2021.102586","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T03:27:30Z","timestamp":1622604450000},"page":"102586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Performance of serum procalcitonin as a biochemical predictor of death in hematology patients with febrile neutropenia"],"prefix":"10.1016","volume":"90","author":[{"given":"Alan Ledif","family":"Reyes Mondrag\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga Graciela","family":"Cant\u00fa-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Cecilia","family":"Garza-Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar Homero","family":"Guti\u00e9rrez-Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perla Roc\u00edo","family":"Colunga Pedraza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz","family":"del Carmen Tar\u00edn-Arzaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Carlos","family":"Jaime-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Angel","family":"Hawing Z\u00e1rate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graciela Alejandra","family":"Gonz\u00e1lez-Cant\u00fa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonel Estanislao","family":"Villalobos-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal Alberto","family":"Jim\u00e9nez-Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymundo","family":"Vera-Pineda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"G\u00f3mez-Almaguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.bcmd.2021.102586_bb0005","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","article-title":"Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bcmd.2021.102586_bb0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/CCM.0b013e31822b50c2","article-title":"Survival in neutropenic patients with severe sepsis or septic shock","volume":"40","author":"Legrand","year":"2012","journal-title":"Crit. Care Med."},{"issue":"7","key":"10.1016\/j.bcmd.2021.102586_bb0015","first-page":"763","article-title":"Causes of fever in cancer patients (prospective study over 477 episodes)","volume":"14","author":"Toussaint","year":"2006","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.bcmd.2021.102586_bb0020","first-page":"1487","article-title":"The multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients","volume":"21","author":"Klastersky","year":"2013","journal-title":"Support. Care Cancer"},{"issue":"6","key":"10.1016\/j.bcmd.2021.102586_bb0025","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/S0021-9258(19)69685-7","article-title":"Procalcitonin is a glycoprotein","volume":"256","author":"Jacobs","year":"1981","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bcmd.2021.102586_bb0030","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0196-9781(01)00541-1","article-title":"Isolation and characterization of serum procalcitonin from patients with sepsis","volume":"22","author":"Wegl\u00f6hner","year":"2001","journal-title":"Peptides."},{"issue":"4","key":"10.1016\/j.bcmd.2021.102586_bb0035","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1515\/cclm-2018-0154","article-title":"Analyzing the capability of PSP, PCT and sCD25 to support the diagnosis of infection in cancer patients with febrile neutropenia","volume":"57","author":"de Guadiana-Romualdo","year":"2019","journal-title":"Clin. Chem. Lab. Med."},{"issue":"8844","key":"10.1016\/j.bcmd.2021.102586_bb0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0140-6736(93)90277-N","article-title":"High serum procalcitonin concentrations in patients with sepsis and infection","volume":"341","author":"Assicot","year":"1993","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bcmd.2021.102586_bb0045","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1086\/421997","article-title":"Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis","volume":"39","author":"Simon","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.bcmd.2021.102586_bb0050","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1097\/01.CCM.0000239116.01855.61","article-title":"Procalcitonin increase in early identification of critically ill patients at high risk of mortality","volume":"34","author":"Jensen","year":"2006","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bcmd.2021.102586_bb0055","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1086\/505394","article-title":"Utility of procalcitonin concentration in the evaluation of patients with malignant diseases and elevated C-reactive protein plasma concentrations","volume":"43","author":"Schuttrumpf","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.bcmd.2021.102586_bb0060","first-page":"3","article-title":"Prognostic factors for mortality with febrile neutropenia in hospitalized patients","volume":"3","author":"Hosiriluck","year":"2015","journal-title":"Southwest Respir. Crit. Care Chron."},{"issue":"6\u20137","key":"10.1016\/j.bcmd.2021.102586_bb0065","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/00365548.2011.554855","article-title":"Elevated procalcitonin predicts gram-negative sepsis in haematological patients with febrile neutropenia","volume":"43","author":"Koivula","year":"2011","journal-title":"Scand. J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.bcmd.2021.102586_bb0070","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"Jama."},{"issue":"1","key":"10.1016\/j.bcmd.2021.102586_bb0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/10428194.2014.911864","article-title":"Initial procalcitonin level predicts infection and its outcome in patients with non-Hodgkin lymphoma with febrile neutropenia","volume":"56","author":"Liu","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bcmd.2021.102586_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/ejh.13161","article-title":"Interleukin-1 receptor antagonist as a biomarker of sepsis in neutropenic haematological patients","author":"Intke","year":"2018","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2021.102586_bb0085","doi-asserted-by":"crossref","first-page":"28090","DOI":"10.1038\/srep28090","article-title":"Procalcitonin as diagnostic marker of infection in solid tumors patients with fever","volume":"6","author":"Vincenzi","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bcmd.2021.102586_bb0090","first-page":"539","article-title":"Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein","volume":"23","author":"von Lilienfeld-Toal","year":"2004","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"10","key":"10.1016\/j.bcmd.2021.102586_bb0095","first-page":"2863","article-title":"Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis","volume":"23","author":"Wu","year":"2015","journal-title":"Support. Care Cancer"},{"issue":"9","key":"10.1016\/j.bcmd.2021.102586_bb0100","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1080\/10428190802258956","article-title":"Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia","volume":"49","author":"Prat","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bcmd.2021.102586_bb0105","doi-asserted-by":"crossref","first-page":"102445","DOI":"10.1016\/j.bcmd.2020.102445","article-title":"Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in northern India","volume":"84","author":"Halder","year":"2020","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2021.102586_bb0110","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s13054-014-0503-3","article-title":"Sepsis-associated hyperlactatemia","volume":"18","author":"Garcia-Alvarez","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.bcmd.2021.102586_bb0115","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1038\/s41598-020-61094-z","article-title":"Calprotectin, a new biomarker for diagnosis of acute respiratory infections","volume":"10","author":"Havelka","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979621000528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979621000528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:35:35Z","timestamp":1761050135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979621000528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":23,"alternative-id":["S1079979621000528"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2021.102586","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of serum procalcitonin as a biochemical predictor of death in hematology patients with febrile neutropenia","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2021.102586","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102586"}}